Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Neumann

Showing results (91-100 of 301) with videos related to

Pageof 31
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2018
A Health Economics Approach to US Value Assessment Frameworks-Introduction: An ISPOR Special Task Force Report [1]Peter J Neumann, Richard J Willke, Louis P Garrison
Annals of Internal Medicine|April 4, 2018
A Call for Open-Source Cost-Effectiveness AnalysisJoshua T Cohen, Peter J Neumann, John B Wong
The American Journal of Managed Care|September 24, 2016
Mapping US commercial payers' coverage policies for medical interventionsJames D Chambers, Matthew D Chenoweth, Peter J Neumann
The New England Journal of Medicine|October 7, 2005
Medicare and cost-effectiveness analysisPeter J Neumann, Allison B Rosen, Milton C Weinstein
JAMA|December 29, 2016
Updated Recommendations for Cost-effectiveness Studies-ReplyGillian D Sanders, Peter J Neumann, Louise B Russell
Health Affairs (Project Hope)|April 12, 2012
Therapies for advanced cancers pose a special challenge for health technology assessment organizations in many countriesPeter J Neumann, Sarah K Bliss, James D Chambers
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 1, 2025
When Do Published Cost-Effectiveness Analyses Include Societal Costs? An Empirical Analysis, 2013-2023Divya Patil, Bengt Liljas, Peter J Neumann, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 14, 2011
Cost-utility analyses of diagnostic laboratory tests: a systematic reviewChiHui Fang, Hansel J Otero, Dan Greenberg, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|January 13, 2015
The lag from FDA approval to published cost-utility evidenceJames D Chambers, Teja Thorat, Junhee Pyo, et al.
Health Policy (Amsterdam, Netherlands)|September 15, 2004
Willingness to pay for avoiding coronary restenosis and repeat revascularization: results from a contingent valuation studyDan Greenberg, Ameet Bakhai, Peter J Neumann, et al.
Pageof 31

Showing results (91-100 of 301) with videos related to

Sort By:
Pageof 31
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2018
A Health Economics Approach to US Value Assessment Frameworks-Introduction: An ISPOR Special Task Force Report [1]Peter J Neumann, Richard J Willke, Louis P Garrison
Annals of Internal Medicine|April 4, 2018
A Call for Open-Source Cost-Effectiveness AnalysisJoshua T Cohen, Peter J Neumann, John B Wong
The American Journal of Managed Care|September 24, 2016
Mapping US commercial payers' coverage policies for medical interventionsJames D Chambers, Matthew D Chenoweth, Peter J Neumann
The New England Journal of Medicine|October 7, 2005
Medicare and cost-effectiveness analysisPeter J Neumann, Allison B Rosen, Milton C Weinstein
JAMA|December 29, 2016
Updated Recommendations for Cost-effectiveness Studies-ReplyGillian D Sanders, Peter J Neumann, Louise B Russell
Health Affairs (Project Hope)|April 12, 2012
Therapies for advanced cancers pose a special challenge for health technology assessment organizations in many countriesPeter J Neumann, Sarah K Bliss, James D Chambers
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 1, 2025
When Do Published Cost-Effectiveness Analyses Include Societal Costs? An Empirical Analysis, 2013-2023Divya Patil, Bengt Liljas, Peter J Neumann, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 14, 2011
Cost-utility analyses of diagnostic laboratory tests: a systematic reviewChiHui Fang, Hansel J Otero, Dan Greenberg, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|January 13, 2015
The lag from FDA approval to published cost-utility evidenceJames D Chambers, Teja Thorat, Junhee Pyo, et al.
Health Policy (Amsterdam, Netherlands)|September 15, 2004
Willingness to pay for avoiding coronary restenosis and repeat revascularization: results from a contingent valuation studyDan Greenberg, Ameet Bakhai, Peter J Neumann, et al.
Pageof 31